Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial

European Respiratory Journal ◽

10.1183/09031936.00039510 ◽

2010 ◽

Vol 36 (6) ◽

pp. 1362-1369 ◽

Author(s):

P. E. Van Schil ◽

P. Baas ◽

R. Gaafar ◽

A. P. Maat ◽

M. Van de Pol ◽

...

Keyword(s):

Phase Ii ◽

Malignant Pleural Mesothelioma ◽

Multicentre Trial ◽

Pleural Mesothelioma ◽

Trimodality Therapy

Download Full-text

Faculty Opinions recommendation of Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732234862.793551909 ◽

2018 ◽

Author(s):

Paul Van Schil

Keyword(s):

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma ◽

Trimodality Therapy

Download Full-text

Randomized Phase II Trial of Adjuvant WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma after Completion of Multimodality Therapy

10.21236/ada566780 ◽

2012 ◽

Author(s):

Lee M. Krug

Keyword(s):

Phase Ii ◽

Malignant Pleural Mesothelioma ◽

Phase Ii Trial ◽

Peptide Vaccine ◽

Multimodality Therapy ◽

Pleural Mesothelioma ◽

Randomized Phase Ii ◽

Download Full-text

Randomized Phase II Trial of Adjuvant WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma after Completion of Multimodality Therapy

10.21236/ada592046 ◽

2013 ◽

Author(s):

Lee M. Krug

Keyword(s):

Phase Ii ◽

Malignant Pleural Mesothelioma ◽

Phase Ii Trial ◽

Peptide Vaccine ◽

Multimodality Therapy ◽

Pleural Mesothelioma ◽

Randomized Phase Ii ◽

Download Full-text

Brief Report: A Phase II Study of Sunitinib in Malignant Pleural Mesothelioma. The NCIC Clinical Trials Group

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3182333df5 ◽

2011 ◽

Vol 6 (11) ◽

pp. 1950-1954 ◽

Author(s):

Scott A. Laurie ◽

Ashish Gupta ◽

Quincy Chu ◽

Christopher W. Lee ◽

Wojciech Morzycki ◽

...

Keyword(s):

Clinical Trials ◽

Phase Ii ◽

Malignant Pleural Mesothelioma ◽

Phase Ii Study ◽

Pleural Mesothelioma

Download Full-text

P2.01: LUME-MeSO: Phase II/III Study of Nintedanib + Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.08.075 ◽

2016 ◽

Vol 11 (10) ◽

pp. S216 ◽

Author(s):

Giorgio V. Scagliotti ◽

Rabab Gaafar ◽

Anna Nowak ◽

Nicholas J. Vogelzang ◽

Ute Von Wangenheim ◽

...

Keyword(s):

Phase Ii ◽

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma

Download Full-text

P3.04-006 SYSTEMS-2: Randomized Phase II Trial of Standard Versus Dose Escalated Radiotherapy for Pain in Malignant Pleural Mesothelioma

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2017.09.1664 ◽

2017 ◽

Vol 12 (11) ◽

pp. S2287

Author(s):

M. Ashton ◽

N. O'Rourke ◽

N. Macleod ◽

S. Smith ◽

R. Valentine ◽

...

Keyword(s):

Phase Ii ◽

Malignant Pleural Mesothelioma ◽

Phase Ii Trial ◽

Pleural Mesothelioma ◽

Randomized Phase Ii

Download Full-text

MALIGNANT PLEURAL MESOTHELIOMA: COMPARISON OF SURGERY-BASED TRIMODALITY THERAPY TO MEDICAL THERAPY AT TWO TERTIARY ACADEMIC INSTITUTIONS

Lung Cancer ◽

10.1016/j.lungcan.2021.04.025 ◽

2021 ◽

Author(s):

Frédéric Larose ◽

Nicholas Quigley ◽

Yves Lacasse ◽

Simon Martel ◽

Loïc Lang-Lazdunski

Keyword(s):

Medical Therapy ◽

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma ◽

Academic Institutions ◽

Trimodality Therapy

Download Full-text

221 A phase II trial to assess the safety and immunological activity of TroVax plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma. The SKOPOS trial

Lung Cancer ◽

10.1016/s0169-5002(14)70221-1 ◽

2014 ◽

Vol 83 ◽

pp. S82

Author(s):

J.F. Lester ◽

A. Casbard ◽

K. Roberts ◽

Z. Tabi ◽

G. Griffiths

Keyword(s):

Phase Ii ◽

Malignant Pleural Mesothelioma ◽

Phase Ii Trial ◽

Pleural Mesothelioma ◽

Immunological Activity

Download Full-text

SAKK 17/16 - Lurbinectedin as second or third line palliative chemotherapy in malignant pleural mesothelioma (MPM): A multi-center, single-arm phase II trial

Annals of Oncology ◽

10.1093/annonc/mdz266.002 ◽

2019 ◽

Vol 30 ◽

pp. v748 ◽

Author(s):

Y. Metaxas ◽

M. Frueh ◽

E.I. Eboulet ◽

F. Grosso ◽

M. Pless ◽

...

Keyword(s):

Phase Ii ◽

Malignant Pleural Mesothelioma ◽

Palliative Chemotherapy ◽

Phase Ii Trial ◽

Pleural Mesothelioma ◽

Download Full-text

174 Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin (PC) followed by extrapleural pneumonectomy (EPP) and radiation (RT) for malignant pleural mesothelioma (MPM)

Lung Cancer ◽

10.1016/s0169-5002(07)70250-7 ◽

2006 ◽

Vol 54 ◽

pp. S42 ◽

Author(s):

L.M. Krug ◽

H.I. Pass ◽

V.W. Rusch ◽

H.L. Kindler ◽

D.J. Sugarbaker ◽

...

Keyword(s):

Phase Ii ◽

Malignant Pleural Mesothelioma ◽

Phase Ii Trial ◽

Extrapleural Pneumonectomy ◽

Pleural Mesothelioma ◽

Multicenter Phase

Download Full-text